Literature DB >> 194921

The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassay.

M C Cheung, J J Albers.   

Abstract

To study apolipoprotein A-II, a simple, precise, and accurate immunodiffusion assay was developed and applied in a population sample of industrial employees. Apolipoprotein A-II (A-II) did not increase with age in men (r = -0.20, n = 172), but showed a slight increase with age in women (0.1 mg/dl per yr, r = 0.20, n = 188). A-II correlated significantly with apolipoprotein A-I (A-I) (r = 0.71) and high density lipoprotein (HDL) cholesterol (men, r = 0.64; women, r = 0.49). The A-I/A-II ratio was significantly related to HDL cholesterol (men, r = 0.29; women, r = 0.44). Women on no medication (n = 92) had A-II levels similar to men (34+/-5 and 33+/-5 mg/dl, mean+/-SD, respectively), whereas women on oral contraceptives or estrogens had significantly higher levels (39+/-6 mg/dl, n = 75, P < 0.01). The plasma A-I/A-II weight ratio was 3.6+/-0.4 for men and 3.8+/-0.5 for women. In the d = 1.10-1.21 subfraction, both males and females had similar A-I, A-II, and HDL cholesterol levels (men: mean, 97, 27, and 32 mg/dl, respectively; women: mean, 104, 28, and 36 mg/dl, respectively). Women had approximately twice the amount of A-I, A-II, and HDL cholesterol than men in the d = 1.063-1.10 fraction (men: mean, 10, 2, and 10 mg/dl, respectively; women: mean, 24, 4, and 19 mg/dl, respectively). The A-I/A-II weight ratio in the d = 1.063-1.10 fraction (men, 5.1+/-0.7; women, 6.1+/-1.3) was significantly greater (P < 0.01) than that in the d = 1.10-1.21 fraction (men, 3.7+/-0.2; women, 3.8+/-0.2). Furthermore, the weight ratio of cholesterol to total apoprotein A in the d = 1.063-1.10 fraction (men, 0.75+/-0.09; women, 0.67+/-0.05) was significantly higher (P < 0.01) than that found in the d = 1.10-1.21 fraction (men, 0.26+/-0.04, women, 0.28+/-0.05). Thus, the compositions of HDL hydrated density subclasses are significantly different from each other. These results suggest that the differences in HDL between men and women are due primarily to differences in the relative proportions of HDL subclasses rather than to the intrinsic differences in HDL structure.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 194921      PMCID: PMC372341          DOI: 10.1172/JCI108767

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  HETEROGENEITY OF PLASMA HIGH DENSITY LIPOPROTEINS.

Authors:  R I LEVY; D S FREDRICKSON
Journal:  J Clin Invest       Date:  1965-03       Impact factor: 14.808

2.  Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men.

Authors:  G G Rhoads; C L Gulbrandsen; A Kagan
Journal:  N Engl J Med       Date:  1976-02-05       Impact factor: 91.245

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Apoprotein composition of very low density lipoproteins of human serum.

Authors:  J P Kane; T Sata; R L Hamilton; R J Havel
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

5.  Quantitation of apolipoprotein A-I of human plasma high density lipoprotein.

Authors:  J J Albers; P W Wahl; V G Cabana; W R Hazzard; J J Hoover
Journal:  Metabolism       Date:  1976-06       Impact factor: 8.694

6.  Structure of human high density lipoprotein reassembled in vitro. Radioimmunoassay studies.

Authors:  G Schonfeld; B Pfleger; R Roy
Journal:  J Biol Chem       Date:  1975-10-10       Impact factor: 5.157

7.  Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays.

Authors:  M D Curry; P Alaupovic; C A Suenram
Journal:  Clin Chem       Date:  1976-03       Impact factor: 8.327

8.  Lipid and lipoprotein measurements in a normal adult American population.

Authors:  F T Lindgren; G L Adamson; L C Jenson; P D Wood
Journal:  Lipids       Date:  1975-12       Impact factor: 1.880

9.  Familial hyper-alpha-lipoproteinemia: studies in eighteen kindreds.

Authors:  C J Glueck; R W Fallat; F Millett; P Gartside; R C Elston; R C Go
Journal:  Metabolism       Date:  1975-11       Impact factor: 8.694

10.  The molar ratio of the two major polypeptide components of human high density lipoprotein.

Authors:  S J Friedberg; J A Reynolds
Journal:  J Biol Chem       Date:  1976-07-10       Impact factor: 5.157

View more
  47 in total

1.  The composition and metabolism of high density lipoprotein subfractions.

Authors:  E J Schaefer; D M Foster; L L Jenkins; F T Lindgren; M Berman; R I Levy; H B Brewer
Journal:  Lipids       Date:  1979-05       Impact factor: 1.880

2.  Quantitation of high density lipoproteins.

Authors:  J J Albers; G R Warnick; M C Chenng
Journal:  Lipids       Date:  1978-12       Impact factor: 1.880

3.  A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates.

Authors:  E A Brinton; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

4.  A splice-junction mutation responsible for familial apolipoprotein A-II deficiency.

Authors:  S S Deeb; K Takata; R L Peng; G Kajiyama; J J Albers
Journal:  Am J Hum Genet       Date:  1990-04       Impact factor: 11.025

5.  Calorimetry of apolipoprotein-A1 binding to phosphatidylcholine-triolein-cholesterol emulsions.

Authors:  A Derksen; D Gantz; D M Small
Journal:  Biophys J       Date:  1996-01       Impact factor: 4.033

6.  Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis.

Authors:  H Dieplinger; P Y Schoenfeld; C J Fielding
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

7.  Monoclonal antibodies to human apolipoprotein AI: probing the putative receptor binding domain of apolipoprotein AI.

Authors:  C M Allan; N H Fidge; J R Morrison; J Kanellos
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

8.  Effects of dietary cholesterol and fatty acids on plasma lipoproteins.

Authors:  G Schonfeld; W Patsch; L L Rudel; C Nelson; M Epstein; R E Olson
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

9.  Usefulness of probucol in treating primary hypercholesterolemia.

Authors:  M Enjalbert; S Lussier-Cacan; S DuBreuil-Quidoz; J LeLorier; J Davignon
Journal:  Can Med Assoc J       Date:  1980-10-18       Impact factor: 8.262

10.  Associations of lecithin: cholesterol acyltransferase (LCAT) mass concentrations with exercise, weight loss, and plasma lipoprotein subfraction concentrations in men.

Authors:  P T Williams; J J Albers; R M Krauss; P D Wood
Journal:  Atherosclerosis       Date:  1990-05       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.